Systemic inflammation as a central player in the initiation and development of Alzheimer's disease
Source
Immunity & ageing - ISSN 1742-4933-22:1 (2025) p. 1-26
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease
Source
Journal of Prevention of Alzheimer's Disease - ISSN 2274-5807-12:8 (2025) p. 1-5
Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data
Source
Alzheimer's research & therapy - ISSN 1758-9193-17:1 (2025) p. 1-15
Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system
Source
Clinical Parkinsonism and Related Disorders - ISSN 2590-1125-12 (2025) p. 1-8
Monoaminergic alterations at the subregional cervical and thoracic spinal cord level of patients within the FTD-ALS continuum and early-onset AD : low thoracic dopaminergic activity in ALS
Source
Journal of neurochemistry - ISSN 0022-3042-169:3 (2025) p. 1-18